HIN
Click for more information
0.00% $2.37 heartware international, inc

approval :yes it is true

  1. pat done
    4,131 Posts.
    clock Created with Sketch.
    21/11/12
    08:53
    Post #: 11086966
    HeartWare International has added a news release to its Investor Relations website.
    Title: HeartWare Receives FDA Approval for HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation for Patients with Advanced Heart Failure

    Date(s): 20-Nov-2012 2:44 PM
    HIN Price at posting: $2.22 Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.